These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study. Bioque M; Parellada E; García-Rizo C; Amoretti S; Fortea A; Oriolo G; Palau P; Boix-Quintana E; Safont G; Bernardo M Eur Psychiatry; 2020 Jul; 63(1):e71. PubMed ID: 32669145 [TBL] [Abstract][Full Text] [Related]
3. Combination of Clozapine With Long-Acting Injectable Antipsychotics in Treatment-Resistant Schizophrenia: Preliminary Evidence From Health Care Utilization Indices. Grimminck R; Oluboka O; Sihota M; Rutherford DL; Yeung H Prim Care Companion CNS Disord; 2020 Jul; 22(4):. PubMed ID: 32678523 [TBL] [Abstract][Full Text] [Related]
4. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
5. Beneficial Effects of Concomitant Long-Acting Injectable Antipsychotics on Time to Rehospitalization in Patients With Treatment-Resistant Schizophrenia Receiving Clozapine: A Retrospective Cohort Study. Tien Y; Wang XY; Huang SC; Huang HP J Clin Psychiatry; 2024 May; 85(2):. PubMed ID: 38696112 [No Abstract] [Full Text] [Related]
6. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study]. Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821 [TBL] [Abstract][Full Text] [Related]
7. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists]. Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914 [TBL] [Abstract][Full Text] [Related]
8. Tachycardia in patients treated with clozapine versus antipsychotic long-acting injections. Nilsson BM; Edström O; Lindström L; Wernegren P; Bodén R Int Clin Psychopharmacol; 2017 Jul; 32(4):219-224. PubMed ID: 28225439 [TBL] [Abstract][Full Text] [Related]
10. Combination of two long-acting injectable antipsychotics in treatment-resistant schizophrenia: A retrospective 12-month mirror-image study. Calvin N; Minischetti L; Salanon F; Llorca PM; Pouchon A; Polosan M; Dondé C Asian J Psychiatr; 2023 Feb; 80():103402. PubMed ID: 36563612 [TBL] [Abstract][Full Text] [Related]
11. Indications for and use of long-acting injectable antipsychotics: consideration from an inpatient setting. Kishimoto T; Sanghani S; Russ MJ; Marsh AN; Morris J; Basu S; John M; Kane JM Int Clin Psychopharmacol; 2017 May; 32(3):161-168. PubMed ID: 28181959 [TBL] [Abstract][Full Text] [Related]
12. The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series. Se Hyun Kim ; Dong Chung Jung ; Yong Min Ahn ; Yong Sik Kim J Psychopharmacol; 2010 Jul; 24(7):981-6. PubMed ID: 19942641 [TBL] [Abstract][Full Text] [Related]
13. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics]. Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464 [TBL] [Abstract][Full Text] [Related]
14. Effect of Clozapine vs Other Second-Generation Antipsychotics on Hospitalization and Seclusion: A Retrospective Mirror-Image Study in a Japanese Public Psychiatric Hospital. Misawa F; Suzuki T; Fujii Y J Clin Psychopharmacol; 2017 Dec; 37(6):664-668. PubMed ID: 29045304 [TBL] [Abstract][Full Text] [Related]
15. Use of clozapine with nonresponsive patients. Markowitz JS; Jackson CW Psychiatr Serv; 1996 Dec; 47(12):1392. PubMed ID: 9117483 [No Abstract] [Full Text] [Related]
16. The effects of adding long-acting injectable antipsychotic drugs to clozapine on relapse and hospitalization in patients with treatment-resistant schizophrenia: a mirror-image retrospective study. Caliskan AM; Karaaslan M; Inanli I; Caliskan S; Arslan M; Esra Cicek I; Eren I Int Clin Psychopharmacol; 2021 Jan; 36(1):30-33. PubMed ID: 33044315 [TBL] [Abstract][Full Text] [Related]
17. Hospitalization resource utilization and costs among Medicaid insured patients with schizophrenia with different treatment durations of long-acting injectable antipsychotic therapy. Bera R; Offord S; Zubek D; Lau G; Lin J; Karson C J Clin Psychopharmacol; 2014 Feb; 34(1):30-5. PubMed ID: 24135840 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice. Kishi T; Fujita K; Furukawa O; Suzuki T; Moriwaki M; Nitta M; Hattori M; Tsunoka T; Chekuri R; Kane JM; Correll CU; Iwata N Asian J Psychiatr; 2013 Jun; 6(3):200-7. PubMed ID: 23642976 [TBL] [Abstract][Full Text] [Related]
19. Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis. Medrano S; Abdel-Baki A; Stip E; Potvin S Psychopharmacol Bull; 2018 Jun; 48(4):25-61. PubMed ID: 30618474 [TBL] [Abstract][Full Text] [Related]
20. Metabolic parameters and long-term antipsychotic treatment: a comparison between patients treated with clozapine or olanzapine. Feng S; Melkersson K Neuro Endocrinol Lett; 2012; 33(5):493-8. PubMed ID: 23090266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]